Organophosphorus ester-induced chronic neurotoxicity

Journal of Occupational Health and Safety - Australia and New Zealand

Volumn 21, Issue 5, 2005, Pages 408-432

  Abou Donia, Mohamed B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Health symptoms; Neurotoxicity; Organophosphorus compounds; Research

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AUTOANTIBODY; BIOLOGICAL MARKER; ESTER; LEPTOPHOS; LUBRICATING AGENT; MUSCARINIC RECEPTOR; MYELIN; NICOTINIC RECEPTOR; ORGANOPHOSPHORUS COMPOUND; PESTICIDE;

APOPTOSIS; ARTICLE; ATAXIA; BRAIN; CELL DEATH; CHEMICAL STRUCTURE; COGNITION; DISEASE SEVERITY; ENZYME INHIBITION; EXPOSURE; GENE EXPRESSION; HUMAN; INTOXICATION; NERVE CELL DEGENERATION; NERVE FIBER; NERVOUS SYSTEM; NEUROTOXICITY; NONHUMAN; SYMPTOMATOLOGY;

EID: 33747481607     PISSN: 08156409     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (142)

1. Abou-Donia, MB. Organophosphorus pesticides. In Chang, LW and Dyer, RS (eds). Handbook of neurotoxicology. New York: Marcel Dekker, Inc, 1994, pp 419-473.
2. Koelle, GB. Protection of cholinesterase against inevitable inactivation by isopropyl fluorophosphate in vitro. J Pharmacol Exp Ther 1946, 88: 232-237.
3. Sussman, JL, Harel, M, Frolow, F, Gefrier, C, Goldman, A, Toker, L and Silman, I. Atomic structure of acetylcholinesterase from Torpedo Californica: a prototypic acetylcholine-binding protein. Science 1991, 253: 872-878.
4. Abou-Donia, MB (ed). Neurotoxicology (2nd ed). Boca Raton, Fl: CRC Press, 1992, pp 3-21.
5. Whittaker, M. The pseudocholinesterase variants: esterase levels and increased resistance to fluoride. Acta Genetics Basel 1994, 14: 281-285.
6. Lockridge, O. Genetic variants of serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 1990, 47: 35-60.
7. Morita, H, Yanagisawa, N, Nakajima, T, Shimizu, M, Hirabayshi, H, Okudera, M, Nohara, M, Midorikawa, M and Mimura, S. Sarin poisoning in Matsumoto, Japan. Lancet 1995, 346: 290-293.
8. Okumura, T, Takasu, N, Ishimatsu, S, Miyanoki, S, Mitsuhashi, M, Kumada, K, Tanaka, K and Hinohara, S. Report on 640 victims of the Tokyo subway Sarin attack. Ann Emerg Med 1995, 28: 129-135.
9. Yokoyama, K, Araki, S, Murata, K, Nishikitani, M, Okumura, T, Ishimatsu, S, Takasu, N and White, RF. Chronic neurobehavioral effects of Tokyo subway Sarin poisoning in relation to posttraumatic stress disorder. Arch Environ Health 1998, 53: 249-256.
10. Masuda, N, Takatsu, M and Morinari, H. Sarin poisoning in Tokyo subway. Lancet 1995, 345: 1446-1447.
11. Smith, MI, Elvove, E and Frazier, WH. The pharmacological action of certain phenol esters with special reference to the etiology of so-called ginger paralysis (second report). Public Health Rep 1930, 45: 2509-2524.
12. Johnson, MK. The delayed neuropathology caused by some organophosphorus esters: mechanism and challenge. Crit Rev Toxicol 1975, 2: 289-316.
13. Abou-Donia, MB. Organophosphorus ester-induced delayed neurotoxicity. Annu Rev Pharmacol Toxicol 1981, 21: 511-548.
14. Abou-Donia, MB and Lapadula, DM. Mechanisms of organophosphorus ester induced delayed neurotoxicity: type I and type II. Annu Rev Pharmacol Toxicol 1990, 30: 405-440.
15. Himuro, K, Murayama, S, Nishiyama, K, Shinoe, T, Iwase, H, Nagao, M, Takatori, T and Kanazawa, I. Distal sensory axonopathy after Sarin intoxification. Neurology 1988, 51: 1195-1197.
16. Davies, OR and Holland, PR Effect of oximes and atropine upon the development of delayed neurotoxic signs in chickens following poisoning by DFP and Sarin. Biochem Pharmacol 1972, 21: 3145-3151.
17. Carrington, CD, Brown, HR and Abou-Donia, MB. Histopathological assessment of triphenyl phosphite neurotoxicity in the hen. Neurotoxicology 1988, 9: 223-234.
18. Abou-Donia, MB and Preissig, SH. Delayed neurotoxicity of leptophos: toxic effects on the nervous system of hens. Toxicol Appl Pharmacol 1976, 35: 269-282.
19. Abou-Donia, MB and Preissig, SH. Delayed neurotoxicity from continuous low-dose oral administration of leptophos to hens. Toxicol Appl Pharmacol 1976, 38: 595-608.
20. Abou-Donia, MB and Graham, DG. Delayed neurotoxicity from long-term low-level topical administration of leptophos to the combs of hens. Toxicol Appl Pharmacol 1978, 46: 199-213.
21. Abou-Donia, MB and Graham, DG. Delayed neurotoxicity of 0-ethyl 0-4-nitrophenyl phenylphosphonothioate: toxic effects of a single oral dose on the nervous system. Toxicol Appl Pharmacol 1979, 48: 57-66.
22. Abou-Donia, MB and Graham, DG. Delayed neurotoxicity of 0-ethyl 0-4-nitrophenyl phenylphosphonothioate: subchronic (90 days) oral administration in hens. Toxicol Appl Pharmacol 1978, 45: 685-700.
23. Abou-Donia, MB, Graham, DG, MacKay, HA and Abdo, KM. Effect of subchronic dermal application of 0-ethyl 0-4-nitrophenyl phenylphosphonothioate or producing delayed neurotoxicity in hens. Neurotoxicology 1983, 4: 247-260.
24. Abou-Donia, MB, Graham, DG, Timmons, PR and Reichert, BL. Delayed neurotoxic and late acute effects of S, S, S-tributyl phosphorotrithioate on the hen: effect of route of administration. Neurotoxicology 1979, 1: 425-447.
25. Abou-Donia, MB, Graham, DG, Abdo, KM and Komeil, AA. Delayed neurotoxic, late acute and cholinergic effects of S, S, S-tributyl phosphorotrithioate (DEF): subchronic (90 days) administration in hens. Toxicology 1979, 14: 229-243.
26. Abou-Donia, MB, Lapadula, DM, Campbell, G and Abdo, KM. The joint neurotoxic action of inhaled methyl butyl ketone vapor and dermally applied 0-ethyl 0-4-nitrophenyl phenylphosphonothioate in hens: potentiating effect, Toxicol Appl Pharmacol 1985, 79: 69-82.
27. Abou-Donia, MB, Makkawy, HM and Campbell, GM. Pattern of neurotoxicity of n-hexane, methyl n-butyl ketone, 2,5-hexanediol and 2,5-hexanedione alone and in combination with 0-ethyl 0-4-nitrophenyl phenylphosphonothioate in hens. J Toxicol Environ Health 1985, 16: 85-100.
28. Abou-Donia, MB and Wilmarth, KR. The joint action of chlorpyrifos and safrotin on the development of delayed neurotoxicity in the hen. Toxicologist 1995, 15: 205.
29. Windheuser, JJ, Haslan, JL, Caldwell, L and Shaffer, RD. The use of N, N-diethyl-ratoluamide to enhance dermal and transdermal delivery of drugs. J Pharm Sci 1982, 21: 1211.
30. Abou-Donia, MB, Goldstein, LB, Jones, KH, Abdel-Rahman, AA, Damodaran, TV, Dechkovskaia, AM, Bullman, SL, Amir, BE and Khan, WA. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. J Toxicol Sci 2001, 60: 305-314.
31. Abdel-Rahman, AA, Shetty, AK and Abou-Donia, MB. Subchronic dermal application of N, N-Diethyl m-Toluamide (DEET) and permethrin to adult rats, alone or in combination, causes diffuse neuronal cell death and cytoskeletal abnormalities in the cerebral cortex and the hippocampus, and Purkinje neuron loss in the cerebellum. Exp Neurol 2001, 172: 153-171.
32. Bloch, H and Hottinger, A. Uber die spezifitat der cholinesterase-hemmung durch tri-o-cresyl phosphat. Zeitschrift Vitaminforschung 1943, 13: 90.
33. Earl, CJ and Thompson, RHS. The inhibitory action of triortho-cresyl phosphate and cholinesterases. Br J Pharmacol 1952, 7: 261-269.
34. Aldridge, WN and Barnes, JM. Further observations on the neurotoxicity of organophosphorus compounds. Biochem Pharmacol 1966, 15: 541-547.
35. Johnson, MK. The delayed neurotoxic effect of some organophosphorus compounds. Br Med Bull 1969, 114: 711-717.
36. Abou-Donia, MB. Involvement of cytoskeletal proteins in the mechanisms of organophosphorus ester delayed neurotoxicity. Clin Exp Pharmacol Physiol 1995, 22: 358-359.
37. Winrow, CJ, Hemming, ML, Allen, DA, Quistad, GB, Casida, JE and Barlow, C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat Genet 2003, 33: 477-485.
38. Schulman, H. Advances in second messenger and phosphorylation research. New York: Raven Press, 1988, pp 39-111.
39. Patton, SE, Lapadula, DM and Abou-Donia, MB. Relationship of tri-o-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord. J Pharmacol Exp Ther 1986, 239: 597-605.
40. Suwita, E, Lapadula, DM and Abou-Donia, MB. Calcium and calmodulin-enhanced in vitro-phosphorylation of hen brain cold-stable microtubules and spinal cord neurofilament triplet proteins after a single oral dose of tri-o-cresyl phosphate. Proceedings of the National Academy of Sciences of the USA 1986, 83: 6174-6178.
41. Abou-Donia, MB, Viana, ME, Gupta, RP and Anderson, JK. Enhanced calmodulin binding concurrent with increased kinase-dependent phosphorylation of cytoskeletal proteins following a single subcutaneous injection of diisopropyl phosphorofluoridate in hens. Neurochem Res 1993, 22: 165-173.
42. 2+/calmodulin (CaM)-dependent phosphorylation by the brain supernatant of diisopropyl phosphorofluoridate (DFP)-treated hen: tau mutants indicate phosphorylation of more amino acids in tau by CaM kinase II. Brain Res 1998, 813: 32-43.
43. Gupta, RP and Abou-Donia, MB. In vivo and in vitro effects of diisopropyl phosphorofluoridate (DFP) on the rate of hen brain tubulin polymerization. Neurochem Res 1994, 19: 435-444.
44. 2+/calmodulin-dependent protein kinase in the brain subcellular fractions of diisopropyl phosphorofluoridate (DFP)-treated hen. Neurochem Res 1995, 20: 1095-1105.
45. Gupta, RP and Abou-Donia, MB. Diisopropyl phosphorofluoridate (DFP) treatment alters calcium-activated proteinase activity and cytoskeletal proteins of the hen sciatic nerve. Brain Res 1995, 677: 162-166.
46. 2+/calmodulin (CaM)-dependent phosphorylation by the brain supernatant of diisopropyl phosphorofluoridate (DFP)-treated hen: tau mutants indicate phosphorylation of more amino acids in tau by CaM kinase II. Brain Res 1998, 813: 32-43.
47. 2+/calmodulin-dependent protein kinase a subunit and its mRNA expression in diisopropyl phosphorofluoridate (DFP)-treated hen central nervous system. Mol Cell Biochem 1998, 181: 29-39.
48. Gupta, RP and Abou-Donia, MB. Tau phosphorylation by diisopropyl phosphorofluoridate (DFP)-treated hen brain supernatant. Biochem Pharmacol 1999, 53: 1799-1806.
49. Gupta, RP, Damodaran, TV and Abou-Donia, MB. C-fos mRNA induction in the central and peripheral nervous systems of diisopropyl phosphorofluoridate (DFP)-treated hens. Neurochem Res 2000, 25: 327-334.
50. Damodaran, TV and Abou-Donia, MB. Alterations in levels of mRNAs coding for glial fibrillary acidic protein (GFAP) and vimentin genes in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP). Neurochem Res 2000, 25: 809-816.
51. Jensen, KF, Lapadula, DM, Anderson, JK, Haykal-Coates, N and Abou-Donia, MB. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J Neurosci Res 1992, 33: 455-460.
52. Abou-Donia, MB. Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health 2003, 58: 484-497.
53. Gershon, S and Shaw, FB. Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet 1961, 1: 1371-1374.
54. Dille, JR and Smith, PW. Central nervous system effects of chronic exposure to organophosphate insecticides. Aerospace Medicine 1964, 35: 475-478.
55. Metcalf, DR and Homes, JH. EEG, psychological and neurological alterations in humans with organophosphorus exposure. Ann N Y Acad Sci 1969, 160: 357-365.
56. Durham, WF, Wolfe, HR and Quinby, GE. Organophosphorus insecticides and mental alertness. Arch Environ Health 1965, 10: 55-66.
57. Tabershaw, IR and Cooper, WC. Sequelae of acute organic phosphate poisoning. J Occup Med 1966, 8: 5-20.
58. Jamal, G. Neurological syndromes of organophosphorus compounds. Adverse Drug React Toxicol Rev 1997, 16: 133-170.
59. Echbichon, DJ and Joy, RM. Pesticides and neurological diseases (2nd ed). Boston: CRC Press, 1995.
60. Savage, EP, Keefe, TF, Mounce, LM, Heaton, RK, Lewis, JA and Burcar, PJ. Chronic neurological sequelae of acute organophosphates pesticide poisoning. Arch Environ Health 1988, 43: 38-45.
61. Maroni, M, Jarvisalo, J and La Ferla, L. The WHO-UNDP epidemiological study on the health effects of exposure to organophosphorus pesticides. Toxicol Lett 1986, 33: 115-123.
62. Rosenstock, L, Keifer, M, Daniell, WE, McConnell, R and Claypoole, K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet 1991, 338: 223-227.
63. Steenland, K, Jenkins, B, Ames, RG, O'Malley, M, Chrislip, D and Russo, J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Public Health 1994, 84: 731-736.
64. McConell, R, Keifer, M and Rosenstock, L. Elevated quantitative vibrotactile threshold among workers previously poisoned with methamidophos and other organophosphate pesticides. Am J Ind Med 1994, 25: 325-334.
65. Callender, TJ, Morrow, L and Subramanian, K. Evaluation of chronic neurological sequelae after acute pesticide exposure using SPEC brain scans. J Toxicol Environ Health 1994, 41: 275-284.
66. Colosio, C, Tiramani, M and Maroni, M. Neurobehavioral effects of pesticides: state of the art. Neurotoxicology 2003, 24: 577-591.
67. Veronesi, B, Jones, K and Pope, C. The neurotoxicity of sub chronic acetylcholinesterase (AChE) inhibition in rat hippocampus. Toxicol Appl Pharmacol 1990, 104: 440-456.
68. Sidell, FR. Soman and Sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol 1974, 7: 1-17.
69. Abdel-Rahman, A, Shetty, AK and Abou-Donia, MB. Acute exposure to Sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships. Neuroscience 2002, 113: 721-741.
70. Yokoyama, K, Araki, S, Murata, K, Nishikitani, M, Okumura, T, Ishimatsu, S, Takasu, N and White, RF. Chronic neurobehavioral effects of Tokyo subway Sarin poisoning in relation to posttraumatic stress disorder. Arch Environ Health 1998, 53: 249-256.
71. Masuda, N, Takatsu, M, Morinari, H and Ozawa, T. Sarin poisoning in Tokyo subway. Lancet 1995, 345: 1446-1447.
72. Niijima, H, Nagaom, I, Nakajiima, M, Takatori, T, Matsuda, Y, Iwase, H and Kobayahsi, M. Sarin-like and Soman-like organophosphorus agents activate PLC in rat brains. Toxicol Appl Pharmacol 1999, 156: 64-69.
73. Petras, JM. Soman neurotoxicity. Fundam Appl Toxicol 1981, 1: 242.
74. Faro, MD and Windle, WF. Transneuronal degeneration in brains of monkey asphyxiated at birth. Exp Neurol 1969, 24: 38-53.
75. Cavanagh, JB and Patangia, GN. Changes in the central nervous system in the cat as the result of tri-o-cresyl phosphate poisoning. Brain 1995, 88: 165-180.
76. McDonough, JH, Dochterman, LW, Smith, CD and Shih, T. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 1995, 15: 123-132.
77. Kadar, T, Cohen, G, Sahar, R, Aikalay, D and Shapira, S. Long-term study of brain lesions following Soman, in comparison to DFP and metrazol poisoning. Hum Exp Toxicol 1992, 11: 517-523.
78. McDonald, BE, Costa, LG and Murphy, SD. Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates. Toxicol Lett 1988, 40: 47-56.
79. Rafaelle, K, Olton, D and Annau, Z. Repeated exposure to diisopropyl fluorophosphate (DFP) produces increased sensitivity to cholinergic antagonists in discrimination retention and reversal. Psychopharmacology 1990, 100: 267-274.
80. Bushnell, PJ, Padilla, SS, Ward, T, Pope, CN and Olszyk, VB. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropyl fluorophosphate. J Pharmacol Exp Ther 1991, 256: 741-750.
81. Kassa, J, Koupilova, M and Vachek, J. The influence of low-level Sarin inhalation exposure on spatial memory in rats. Pharmacol Biochem Behav 2001, 70: 175-179.
82. Duffy, FH, Burchfield, JL, Bartels, PH, Gaon, M and Sim, VM. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol 1979, 47: 161-176.
83. West, I. Sequelae of poisoning from phosphate ester pesticides. Industrial Medicine and Surgery 1968, 37: 832-836.
84. Shih, T-M, Duniho, SM and McDonough, JH. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 2003, 188: 69-80.
85. Lemercier, G, Carpentier, P, Setenac-Roumanou, H and Moralis, P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol 1983, 61: 123-129.
86. Petras, JM. Neurology and neuropathology of Soman-induced brain injury: an overview. Journal of Experimental and Analytical Behavior 1994, 61: 319-329.
87. Carpentier, P, Delamanche, IS, Lebert, M, Blanchet, G and Bouchard, C. Seizure-related opening of the blood brain barrier induced by Soman: possible correlation with the acute neuropathology observed in poison rats. Neurotoxicology 1990, 11: 493-508.
88. Clement, JG and Broxup, B. Efficacy of diazepam and avizafone against Soman-induced neuropathology in brain of rats. Neurotoxicology 1993, 14: 485-504.
89. Shih, T-M, Koviak, TA and Capacio, BR. Anticonvulsants for poisoning by the organophosphorus compound Soman: pharmacological mechanisms. Neurosci Biobehav Rev 1991, 15: 349-362.
90. Pazdernik, TL, Emerson, MR, Cross, R, Nelson, SR and Samson, FE. Soman-induced seizures: limbic activity, oxidative stress, and neuroprotective proteins. J Appl Toxicol 2001, 21: S87-S94.
91. De Groot, DM, Bierman, EP, Bruijnzeel, PL, Carpentier, P, Kulig, BM, Lallement, G, Melchers, BP, Philippens, IH and van Huygevoort, AH. Beneficial effects of TCP on Soman intoxification in guinea pigs: seizures, brain damage, and learning behavior. J Appl Toxicol 2001, 21: S57-S65.
92. Taysee, L, Calvet, JH, Buee, J, Christin, D, Delamanche, S and Breton, P. Comparative efficacy of diazepam and avizafone against Sarin-induced neuropathology and respiratory failure in guinea pigs: influence of atropine dose. Toxicology 2003, 188: 197-209.
93. McLeod, CG, Singer, AW and Harrington, DG. Acute neuropathology in Soman-poisoned rats. Neurotoxicology 1984, 5: 53-58.
94. Churchill, L, Pazdernik, TL and Jackson, JL. Soman-induced brain lesions demonstrated by muscarinic receptor autoradiography. Neurotoxicology 1985, 6: 81-90.
95. Baille, V, Dorandeu, F, Carpentier, P, Bizot, JC, Filliat, P, Four, E, Denis, J and Lallement, G. Acute exposure to a low or mild dose of Soman: biochemical, behavioral and histopathological effects. Pharmacol Biochem Behav 2001, 69: 561-569.
96. Kim, Y-B, Hur, GH, Shin, S, Sok, D-E, Kang, J-K and Lee, Y-S. Organophosphate-induced brain injuries: delayed apoptosis mediated by nitric oxide. Environ Toxicol Pharmacol 1999, 7: 147-152.
97. Levin, HS, Rodnitsky, RL and Mick, DL. Anxiety associated with exposure to organophosphorus compounds. Arch General Psychiatry 1976, 33: 225-228.
98. Stokes, L, Stark, A, Marshall, E and Narang, A. Neurotoxicity among pesticide applicators exposed to organophosphates. Occup Environ Med 1995, 52: 648-653.
99. Fielder, N, Feldman, RG, Jacobson, J, Rahill, A and Wetherell, A. The assessment of neuro-behavioral toxicity: SOGOMSEC joint report. Environ Health Perspect 1996, 104(Suppl 2): 179-191.
100. Bazylewicz-Walczak, B, Majczakowa, W and Szymczak, M. Behavioral effects of occupational exposure to organophosphorus pesticides in female greenhouse planting workers. Neurotoxicology 1999, 20: 819-826.
101. Srivastava, AK, Gupta, BN, Bihari, V, Mathur, N, Srivastava, LP and Pangenty, BS. Clinical, biochemical and neurobehavioral studies on workers engaged in the manufacture of quinalphos. Food Chemistry and Toxicology 2000, 38: 65-69.
102. Kaplan, JG, Kessler, J, Rosenberg, N, Pack, D and Schaumberg, H. Sensory neuropathy associated with Dursban (chlorpyrifosa) exposure. Neurology 1993, 43: 2193-2196.
103. Kilburn, KH. Evidence for chronic neurobehavioral impairment from chlorpyrifos and organophosphate insecticide (Dursban) used indoors. Environ Epidemiol Toxicol 1999, 1: 153-162.
104. Blondell, J and Dobozy, VA. Review of chlorpyrifos poisoning data. Washington, DC: United States Environmental Protection Agency, 14 January 1997.
105. Abou-Donia, MB, Abdel-Rahman, AA, Goldstein, LB, Dechkovskaia, AM, Shah, DU, Bullman, SL and Khan, WA. Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats. Arch Toxicol 2003, 77: 452-458.
106. Abdel-Rahman, AA, Dechkovskaia, AM, Mehta-Simmons, H, Guan, XR and Khan, WA. Increased expression of glial fibrillary acidic protein in cerebellum and hippocampus: differential effects on neonatal brain regional acetylcholinesterase following maternal exposure to combined chlorpyrifos and nicotine. J Toxicol Environ Health A 2003, 66: 2047-2066.
107. Eng, LF and Ghirnikar, RS. GFAP and astrogliosis. Brain Pathol 1994, 4: 229-237.
108. Abdel-Rahman, AA, Dechkovskaia, AM, Goldstein, LB, Bullman, SH, Khan, WA, El-Masry, E and Abou-Donia, MB. Neurological deficits induced by malathion, DEET and permethrin, alone or in combination in adult rats. J Toxicol Environ Health A 2003, 67: 331-356.
109. London, L, Myers, JE, Neil, V, Taylor, T and Thompson, ML. An investigation into neurological and neurobehavioral effects of long-term agrochemical use among deciduous fruit farm workers in the Western Cape, South Africa. Environ Res 1997, 73: 132-145.
110. Pilkington, A, Buchanan, D, Jamal, GA, Gillham, R, Hansen, S and Kidd, M. An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neurophysiological abnormalities in sheep farmers and dippers. Occup Environ Med 2001, 58: 702-710.
111. Nishiwaki, Y, Maekawa, K, Ojawa, Y, Asukai, N, Minami, M and Omae, K. Sarin health effects study group. Environ Health Perspect 2001, 109: 1169-1173.
112. Institute of Medicine of the National Academies. Health consequences of service during the Persian Gulf War: initial findings and recommendation for immediate action. Washington, DC: US Institute of Medicine, 1995.
113. Committee on Veterans Affairs. Report of the special investigation unit on Gulf War illnesses. 105th US Congress, 2nd session, SPRT105-139. Washington, DC: US Senate/US Government Printing Office, 1998.
114. Horner, RD, Kamins, KG and Feussner, JR. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2003, 6: 742-749.
115. Haley, RW. Excess incidence of ALS in young Gulf War veterans. Neurology 2003, 61: 750-756.
116. Van Netten, C. Air quality and health effects associated with the operation of BAe 146-200 aircraft. Appl Occup Environ Hyg 1998, 13: 733-739.
117. Witkowski, C. Remarks on airliner air quality. American Society of Heating, Refrigerating and Air-Conditioning Engineers Conference, Chicago, 24 January 1999.
118. Hunter, D, Perry, KMA and Evans, RB. Toxic polyneuritis arising during the manufacture of tricresyl phosphate. Br J Ind Med 1994, 1: 227-231.
119. Hewstone, RK. Environmental health aspects of lubricant additives. Sci Total Environ 1994, 156: 243-254.
120. Siegel, J, Rudolph, HS, Getzkin, AJ and Jones, RA. Effects on experimental animals of long-term continuous inhalation of triaryl phosphate hydraulic fluid. Toxicol Appl Pharmacol 1965, 7: 543-549.
121. Barrett, DS and Ochme, FW. A review of organophosphorus ester-induced delayed neurotoxicity. Vet Hum Toxicol 1985, 27: 23-37.
122. Freudenthal, RI, Rausch, L, Gerhart, JM, Barth, ML, Mackerer, CR and Bisinger, EC. Subchronic neurotoxicity of oil formulations containing either tricresyl phosphate or tri-orthocresyl phosphate. Journal of the College of Toxicology 1993, 12: 409-416.
123. Van Netten, C and Leung, V. Comparison of the constituents of two jet engine lubricating oils and their volatile pyrolytic degradation products. Appl Occup Environ Hyg 2000, 15: 277-283.
124. Solberg, Y and Belkin, M. The role of excitotoxicity in organophosphorus nerve agents central poisoning. Trends Pharmacol Sci 1997, 8: 183-185.
125. Raveh, L, Chapman, S, Cohen, G, Alkalay, D, Gilat, E, Rabinowitz, I and Weissman, BA. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against Soman poisoning. Neurotoxicology 1999, 20: 551-560.
126. Olney, JW. Inciting excitotoxic cytocide among central neurons. Adv Exp Med Biol 1986, 203: 631-645.
127. Choi, DW. Excitotoxic cell death. J Neurobiol 1992, 23: 1261-1276.
128. 2+-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol Lett 1992, 64-65 (Spec no): 357-364.
129. Dawson, TM, Dawson, VL and Snyder, SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992, 32: 297-231.
130. Montague, PR, Gancayco, CD, Winn, MJ, Marchase, RB and Fieldlander, MJ. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 1994, 263: 973-977.
131. Bagetta, G, Massoud, R, Rodino, P, Federici, G and Nistico, G. Systematic administration of lithium chloride and tacrine increases nitric oxide synthase activity in the hippocampus of rats. Eur J Pharmacol 1993, 237: 61-64.
132. Kim, Y-B, Hui, G-H, Lee, Y-S, Han, B-G and Shin, S. A role of nitric acid oxide in organophosphate-induced convulsions. Environ Toxicol Pharmacol 1997, 13: 53-56.
133. Tsujimoto, Y. Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes. Cell Death Differ 1997, 4: 429-434.
134. Murphy, AN, Fiskum, G and Beal, MK. Mitochondria in neurodegeneration: cell life and death. J Cereb Blood Flow Metab 1999, 19: 231-245.
135. Floyd, RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proceedings of the Society of Experimental Biology and Medicine 1999, 222: 236-245.
136. Gupta, RP, Milatovic, D and Dettbarn, WD. Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: protection by antioxidants. Neurotoxicology 2001, 22: 271-282.
137. Lieberman, AD, Craven, MR, Lewis, HA and Nemenzo, JH. Genotoxicity from domestic use of organophosphorus pesticides. J Occup Environ Med 1998, 40: 954-957.
138. Sberna, G, Saez-Valero, J, Li, QX, Czech, C, Beyreuther, K, Masters, CL, Mclean, CA and Small, DH. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the B-amyloid protein pre-cursor of Alzheimer's disease. J Neurochem 1998, 71: 723-731.
139. Calderon, FH, von Bernhardi, R, de Ferrari, G, Luza, S, Aldunate, R and Inestrosa, NC. Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Molecular Psychology 1998, 3: 247-255.
140. Damodaran, TV, Jones, KH, Patel, AG and Abou-Donia, MB. Sarin (nerve agent GB)-induced differential expression of mRNA coding for the acetylcholinesterase gene in the rat central nervous system. Biochem Pharmacol 2003, 65: 2041-2047.
141. Yang, L, Heng-Yi, H and Zhang, X-J. Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells. Neurosci Res 2002, 42: 261-268.
142. Andres, C, Seidman, S, Beeri, R, Timberg, R and Soreq, H. Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact. Neurochem Int 1998, 32: 449-456.